Adaptimmune Therapeutics (ADAP) Stock Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ADAP Stock Alerts $1.08 +0.02 (+1.42%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Adaptimmune Therapeutics Stock Price Performance5 Day Performance-0.46%1 Month Performance-31.96%3 Month Performance+35.39%6 Month Performance+95.45%Year-To-Date Performance+35.56%1 Year Performance-24.30% Receive ADAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide ADAP Stock Chart for Monday, April, 29, 2024 ADAP Chart by TradingView Adaptimmune Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$1.06$1.08+1.42%$1.09$1.031.16 million shs$178.16 million04/25/2024$1.08$1.06-1.85%$1.10$1.04565,527 shs$1.05 billion04/24/2024$1.14$1.08-5.26%$1.15$1.07777,793 shs$1.07 billion04/23/2024$1.01$1.14+12.87%$1.16$1.011.13 million shs$1.13 billion04/22/2024$0.98$1.01+3.41%$1.08$0.95694,241 shs$1.00 billion04/19/2024$0.90$0.98+8.72%$1.08$0.921.48 million shs$971.05 million Get the Latest News and Ratings for ADAP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.99$0.90-8.98%$0.99$0.873.32 million shs$893.20 million04/17/2024$1.03$0.99-4.17%$1.05$0.931.22 million shs$981.29 million04/16/2024$1.05$1.03-1.90%$1.06$0.981.22 million shs$1.02 billion04/15/2024$1.16$1.05-9.48%$1.21$1.051.32 million shs$1.04 billion04/12/2024$1.29$1.16-10.08%$1.28$1.133.08 million shs$1.15 billion04/11/2024$1.27$1.29+1.57%$1.34$1.26877,248 shs$1.28 billion04/10/2024$1.37$1.27-7.30%$1.33$1.251.47 million shs$1.26 billion04/09/2024$1.36$1.37+0.74%$1.41$1.35718,135 shs$1.36 billion04/08/2024$1.37$1.36-0.73%$1.40$1.331.02 million shs$1.35 billion04/05/2024$1.35$1.37+1.48%$1.42$1.321.21 million shs$1.36 billion04/04/2024$1.38$1.35-2.17%$1.45$1.35777,340 shs$1.34 billion04/03/2024$1.40$1.38-1.43%$1.42$1.351.64 million shs$1.37 billion04/02/2024$1.47$1.40-4.76%$1.46$1.361.11 million shs$1.39 billion04/01/2024$1.58$1.47-6.96%$1.55$1.451.33 million shs$1.46 billion03/29/2024$1.58$1.58$1.65$1.531.07 million shs$1.57 billion03/28/2024$1.58$1.58$1.65$1.531.07 million shs$1.57 billion03/27/2024$1.52$1.58+3.95%$1.63$1.471.18 million shs$1.57 billion03/26/2024$1.44$1.52+5.56%$1.57$1.381.19 million shs$1.51 billion03/25/2024$1.44$1.44$1.56$1.421.18 million shs$1.43 billion03/22/2024$1.34$1.44+7.46%$1.48$1.321.67 million shs$1.43 billion03/21/2024$1.33$1.34+0.75%$1.40$1.291.15 million shs$1.33 billion03/20/2024$1.41$1.33-5.67%$1.44$1.243.08 million shs$1.32 billion03/19/2024$1.47$1.41-4.08%$1.52$1.381.18 million shs$1.40 billion03/18/2024$1.48$1.47-0.68%$1.51$1.371.09 million shs$1.46 billion03/15/2024$1.46$1.48+1.37%$1.49$1.42633,191 shs$1.47 billion03/14/2024$1.59$1.46-8.18%$1.56$1.411.34 million shs$1.45 billion03/13/2024$1.49$1.59+6.71%$1.70$1.481.40 million shs$1.58 billion03/12/2024$1.54$1.49-3.25%$1.55$1.421.62 million shs$1.48 billion03/11/2024$1.75$1.54-12.00%$1.80$1.522.09 million shs$1.53 billion03/08/2024$1.74$1.75+0.57%$2.05$1.7212.00 million shs$1.74 billion03/07/2024$1.71$1.74+1.75%$1.85$1.622.53 million shs$1.73 billion03/06/2024$1.46$1.71+17.12%$1.75$1.492.21 million shs$1.70 billion03/05/2024$1.48$1.46-1.35%$1.53$1.38815,506 shs$1.45 billion03/04/2024$1.59$1.48-6.92%$1.64$1.421.12 million shs$1.47 billionRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide03/01/2024$1.57$1.59+1.27%$1.64$1.55923,339 shs$1.58 billion02/29/2024$1.61$1.57-2.48%$1.61$1.501.53 million shs$1.56 billion02/28/2024$1.71$1.61-5.85%$1.77$1.501.71 million shs$1.60 billion02/27/2024$1.64$1.71+4.27%$1.79$1.602.21 million shs$1.70 billion02/26/2024$1.48$1.64+10.81%$1.64$1.431.66 million shs$1.63 billion02/23/2024$1.38$1.48+7.25%$1.50$1.38807,972 shs$1.47 billion02/22/2024$1.50$1.38-8.00%$1.64$1.381.98 million shs$1.37 billion02/21/2024$1.26$1.50+19.05%$1.57$1.232.82 million shs$1.49 billion02/20/2024$1.20$1.26+5.00%$1.32$1.181.09 million shs$1.25 billion02/19/2024$1.20$1.20$1.28$1.18786,500 shs$1.19 billion02/16/2024$1.25$1.20-4.00%$1.28$1.18786,588 shs$1.19 billion02/15/2024$1.28$1.25-2.34%$1.32$1.22694,962 shs$1.24 billion02/14/2024$1.20$1.28+7.11%$1.32$1.20734,128 shs$1.27 billion02/13/2024$1.21$1.20-1.24%$1.29$1.151.06 million shs$1.19 billion02/12/2024$1.25$1.21-3.20%$1.28$1.191.09 million shs$1.20 billion02/09/2024$1.15$1.25+8.70%$1.33$1.191.49 million shs$1.24 billion02/08/2024$1.24$1.15-7.26%$1.27$1.121.57 million shs$1.14 billion02/07/2024$1.33$1.24-6.77%$1.42$1.202.15 million shs$1.23 billion02/06/2024$1.17$1.33+13.68%$1.38$1.133.01 million shs$1.32 billion02/05/2024$1.04$1.17+12.50%$1.20$1.073.13 million shs$1.16 billion02/02/2024$1.00$1.04+4.00%$1.06$0.922.34 million shs$1.03 billion02/01/2024$0.96$1.00+4.17%$1.10$0.985.50 million shs$994.21 million01/31/2024$0.87$0.96+9.74%$1.04$0.904.59 million shs$954.44 million01/30/2024$0.79$0.87+10.18%$0.88$0.7619.98 million shs$869.74 million01/29/2024$0.73$0.79+8.77%$0.80$0.73562,311 shs$789.40 million Related Companies: SRRK Stock Price Chart TARS Stock Price Chart VIR Stock Price Chart AUTL Stock Price Chart FDMT Stock Price Chart BCRX Stock Price Chart IMTX Stock Price Chart KYTX Stock Price Chart RGNX Stock Price Chart ADMA Stock Price Chart Receive ADAP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADAP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.